Central Pacific Bank Trust Division Purchases Shares of 2,753 Astrana Health, Inc. (NASDAQ:ASTH)

Central Pacific Bank Trust Division bought a new position in shares of Astrana Health, Inc. (NASDAQ:ASTH) in the third quarter, according to the company in its most recent filing with the SEC. The fund bought 2,753 shares of the company’s stock, valued at approximately $160,000.

Analyst Ratings Changes

A number of analysts have recently issued reports on the company. BTIG Research boosted their target price on Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a report on Thursday. Robert W. Baird boosted their target price on Astrana Health from $54.00 to $67.00 and gave the stock an “outperform” rating in a report on Thursday, August 15th. Truist Financial boosted their target price on Astrana Health from $50.00 to $59.00 and gave the stock a “buy” rating in a report on Friday, August 9th. Finally, Stifel Nicolaus boosted their target price on Astrana Health from $48.00 to $60.00 and gave the stock a “buy” rating in a report on Thursday, August 1st. Five research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Astrana Health presently has an average rating of “Buy” and a consensus price target of $61.20.

Astrana Health Stock Performance

Astrana Health stock opened at $59.89 on Friday. The stock’s 50 day moving average price is $51.12 and its 200 day moving average price is $44.54. The firm has a market capitalization of $3.36 billion, a PE ratio of 45.37, a price-to-earnings-growth ratio of 2.15 and a beta of 1.21. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.84 and a current ratio of 1.84. Astrana Health, Inc. has a one year low of $28.86 and a one year high of $61.51.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings results on Wednesday, August 7th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.39 by $0.01. The firm had revenue of $486.30 million for the quarter, compared to analyst estimates of $440.68 million. Astrana Health had a return on equity of 10.71% and a net margin of 4.30%. Astrana Health’s revenue for the quarter was up 39.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.28 EPS. As a group, sell-side analysts expect that Astrana Health, Inc. will post 1.33 EPS for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.